Oxidative metabolism of endocannabinoids

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 2-3, 2002, Pages 211-220

  Kozak, K R ^a   Marnett, L J ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CANNABINOID; CYTOCHROME P450; ICOSANOID; LIPID; LIPOXYGENASE; OXYGENASE; PRODRUG; PROSTAGLANDIN SYNTHASE; ENDOCANNABINOID;

AEROBIC METABOLISM; CANCER INHIBITION; DRUG INDUCED DISEASE; FOOD INTAKE; HUMAN; LIPID HYDROLYSIS; LIPID OXIDATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CANNABINOIDS; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; ENDOCANNABINOIDS; LIPOXYGENASE; OXIDATION-REDUCTION; PRODRUGS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION;

EID: 0036019390     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0359     Document Type: Article

References (56)

1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
2. 2-Arachidonylglycerol: A possible endogenous cannabinoid receptor ligand in brain
3. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
4. Comparative biology of the endocannabinoid system possible role in the immune response
5. Endocannabinoids and vascular function
6. Endocannabinoids and fatty acid amides in cancer, inflammation, and related disorders
7. The endocannabinoid system: A physiological perspective on its role in psychomotor control
8. Endocannabinoids as cardiovascular modulators
9. 2-Arachidonoylglycerol and the cannabinoid receptors
10. Cellular signal transduction by anandamide and 2-arachidonoylglycerol
11. Cannabimimetic fatty acid derivatives in cancer and inflammation
12. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
13. Anandamide amidohydrolase (fatty acid amide hydrolase)
14. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis
15. Cyclooxygenases: Structural, cellular, and molecular biology
16. Cyclooxygenases 1 and 2
17. Cyclooxygenase in biology and disease
18. Phospholipid precursors of prostaglandins
19. The action of prostaglandin synthetase on 2-arachidonyl-lecithin
20. 2 ethanolamide from anandamide by cyclooxygenase-2
21. The dynamics of prostaglandin H synthases
22. Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
23. A second endogenous cannabinoid that modulates long-term potentiation
24. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
25. Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues
26. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
27. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand
28. Anandamide hydrolysis by human cells in culture and brain
29. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase
30. Anandamide amidohydrolase activity in rat brain microsomes
31. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide
32. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation
33. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
34. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol
35. A lipoxygenase in rabbit reticulocytes which attacks phospholipids and intact mitochondria
36. Oxygenation of phosphatidylcholine by human polymorphonuclear leukocyte 15-lipoxygenase
37. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein
38. Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist
39. Oxygenation of arachidonylethanolamide (anandamide) by lipoxygenases
40. Anandamide hydroxylation by brain lipoxygenase: Metabolite structures and potencies at the cannabinoid receptor
41. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): Their affinities for cannabinoid receptors and pathways of inactivation
42. Probing the substrate alignment at the active site of 15-lipoxygenases by targeted substrate modification and site-directed mutagenesis. Evidence for an inverse substrate orientation
43. Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase
44. Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonate monooxygenase
45. The CYP P450 arachidonic acid monooxygenases: From cell signaling to blood pressure regulation
46. The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism
47. Microsomal cytochrome P450-mediated liver and brain anandamide metabolism
48. Oxidative metabolism of anandamide
49. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain
50. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid
51. Cannabimimetic fatty acid derivatives: The anandamide family and other endocarmabinoids
52. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor
53. The pharmacology of bimatoprost
54. Metabolism of prostaglandins
55. Prostaglandins and thromboxanes
56. Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo